About American Gene Technologies
American Gene Technologies is a company based in Rockville (United States) founded in 2008. It operates as a HealthTech. American Gene Technologies has raised $53.14 million across 10 funding rounds from investors including NIH, HHS and Ride Wave Ventures. American Gene Technologies offers products and services including HIV Gene Therapy, Immuno-Oncology Therapy, and Phenylketonuria Treatment. American Gene Technologies operates in a competitive market with competitors including Alnylam, Ultragenyx, BioMarin Pharmaceutical, Mirum Pharmaceuticals and Homology Medicines, among others.
- Total Equity Funding$53.14M (USD)
in 10 rounds
- Latest Funding Round$310K (USD), Series B
Nov 2025
- InvestorsNIH
& 2 more
Products & Services of American Gene Technologies
American Gene Technologies offers a comprehensive portfolio of products and services, including HIV Gene Therapy, Immuno-Oncology Therapy, and Phenylketonuria Treatment.
Gene therapy developed to potentially cure HIV infection.
Therapy designed to combat cancer using gene technology.
Treatment developed for Phenylketonuria with FDA orphan approval.
Apps and channels of American Gene Technologies
its YouTube channel American Gene Technologies® has 14.4K subscribers and 30 videos.
Videos from American Gene Technologies
The most watched videos on American Gene Technologies's YouTube channel, American Gene Technologies® (14.4K subscribers). Click a video to play it here.
More on American Gene Technologies®.
Funding Insights of American Gene Technologies
American Gene Technologies has successfully raised a total of $53.14M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $310 thousand completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.14M
- Total Rounds 10
- Last Round Series B — $310,000
- First Round $181,796
(Mar 2012)
- Investors Count 3
All 10 funding rounds of American Gene Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $310,000 | Series B | – | – | – |
| Apr 2022 | $50M | Series B | – | Ride Wave Ventures | – |
| Nov 2015 | $1.16M | Series A | – | – | – |
| Sep 2015 | $232,199 | Grant | – | – | |
| Aug 2015 | $232,199 | Grant | – | – | |
| Jun 2015 | $308,697 | Grant | – | – | |
| Oct 2014 | $340,992 | Seed | – | – | – |
| Sep 2013 | $1.32M | Seed | – | – | – |
| Apr 2012 | $181,796 | Grant | – | – | |
| Mar 2012 | $181,796 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in American Gene Technologies
American Gene Technologies has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Ride Wave Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused biotechnology companies | – | ridewaveventures.tcc.mode | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for American Gene Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of American Gene Technologies
26 people are tracked at American Gene Technologies (7 in leadership, 5 in board & advisors, 14 in team).
| Name | Role | Group |
|---|---|---|
Harold Strait | Head Of Investor Relations | Leadership |
Irene Tennant | Vice President, Clinical Development and Regulatory Affairs | Leadership |
Edmund Cronin | Executive Director of Marketing | Leadership |
Lola Liao | Director of Finance & Administration | Leadership |
Jeff Galvin | CEO & Founder | Leadership |
Barry H. Wells | Head of Business Development | Leadership |
Doug Toal | Lab Director | Leadership |
Qi Tang | Director | Board & advisors |
Jason T. Thompson | Director | Board & advisors |
Robert R. Redfield | Advisor | Board & advisors |
Aaron Galvin | Director | Board & advisors |
Tommy Thompson | Advisor | Board & advisors |
Lihua Liang | Lab Technical Consultant | Team |
Janne Cabrol | Lab Technician | Team |
Saltanat Slocum | Contract Administrator Specialist | Team |
William Duong | Lab Operations Specialist | Team |
Gerald Farrokh Daneshvar | Business Development Executive | Team |
Li Jiang | Senior Accounting Manager | Team |
Sabrina Campbell | Lab Manager | Team |
Natalie Ferguson | Creative Marketing Specalist | Team |
6 more people are available in the full profile.
Complete people profiles for American Gene Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of American Gene Technologies
3 dated milestones of American Gene Technologies across 17 years, from founding to its latest funding, stage changes and deals.
- Founded American Gene Technologies is founded.
- Funding First funding round of $182K.
- Funding Latest funding round, Series B, of $310K.
Competitors of American Gene Technologies
American Gene Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alnylam, Ultragenyx, BioMarin Pharmaceutical, Mirum Pharmaceuticals and Homology Medicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. | |
| ultragenyx.com | 2010 | Novato, United States | $135.1M | 837 | Therapeutics for rare and ultra-rare metabolic diseases are developed. | |
| biomarin.com | 1997 | San Rafael, United States | $37.5M | 2,124 | Therapeutics for rare genetic diseases are developed by BioMarin Pharmaceutical. | |
| mirumpharma.com | 2018 | Menlo Park, United States | $120M | 196 | Small molecule therapeutics are developed for rare diseases treatment. | |
| homologymedicines.com | 2015 | Lexington, United States | $127M | 221 | Developer of gene therapies for rare genetic diseases | |
| imbedbio.com | 2010 | Madison, United States | $22.7M | 35 | Nanotech-based wound care products are developed and provided. | |
| pharvaris.com | 2015 | Leiden, Netherlands | $164.21M | – | Orally deliverable bradykinin B2 antagonists are developed for hereditary angioedema. | |
| uniqure.com | 1998 | Amsterdam, Netherlands | $111M | – | Gene-based therapies are developed for genetic and acquired diseases. | |
| proqr.com | 2012 | Leiden, Netherlands | $57.99M | – | RNA-based therapeutics are developed for genetic retinal disorders. | |
| airna.com | 2021 | Cambridge, United States | $245M | – | Developer of gene therapies for rare and common diseases |
Detailed competitors of American Gene Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of American Gene Technologies
The website of American Gene Technologies (americangene.com) receives about 16.6K visits a month and ranks #1,411,276 among all websites worldwide, #1,829 in Biotechnology and Pharmaceuticals.
- Monthly visits16.6K
▼ 24.4% vs previous month
- Unique visitors10.7K
per month
- Global rank#1,411,276
among all websites
- Category rank#1,829
Health · Biotechnology and Pharmaceuticals
- Bounce rate59%
- Pages per visit1.3
- Average visit11 sec
- DevicesDesktop 18% · Mobile 82%
Websites whose visitors overlap most with American Gene Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| immunomix.com | 100% | 2.7K | #5,105,289 | View details | |
| senseibio.com | 99% | 4.5K | #4,696,262 | View details | |
| maxcyte.com | 98% | 11.2K | #1,958,980 | View details | |
| viivhealthcare.com | 73% | 75.5K | #357,585 | View details | |
| macrogenics.com | 66% | 10.4K | #2,000,657 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for American Gene Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on American Gene Technologies
Complete news archive for American Gene Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to American Gene Technologies
10 companies that operate in the same segment as American Gene Technologies (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about American Gene Technologies
American Gene Technologies was founded in 2008 and raised its 1st funding round 4 years after it was founded.
American Gene Technologies is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
American Gene Technologies is a funded company, having raised a total of $53.14M across 10 funding rounds to date. The company's 1st funding round was a Grant of $181.8K, raised on Mar 2012.
American Gene Technologies is engaged in the development of gene and cell therapies targeting serious diseases. The company, based in Rockville, Maryland, is involved in clinical-stage biotechnology with a focus on creating potential cures for HIV, cancer through Immuno-Oncology, and Phenylketonuria (PKU). Solutions are built on a gene therapy platform aimed at reducing the time and costs of drug development. Research and clinical trials, such as the AGT103-T Phase 1 trial for HIV, are conducted to achieve medical breakthroughs. The company holds multiple patents, including eight for ImmunoTox technology in cancer treatment.
American Gene Technologies's top competitors include Alnylam, UniQure and Imbed Biosciences.
American Gene Technologies offers HIV Gene Therapy, Immuno-Oncology Therapy, and Phenylketonuria Treatment.
American Gene Technologies has 3 investors. Key investors include NIH, HHS, and Ride Wave Ventures.
American Gene Technologies operates through American Gene Technologies Inc..